Product image of Motusol Max 12-Hour Pain Relief (Diclofenac Diethylamine) supplied by GNH India

Motusol Max 12-Hour Pain Relief

Active Ingredient:
Diclofenac Diethylamine
Origin:
EU

Motusol Max 12-Hour Pain Relief (Diclofenac Diethylamine)

Diclofenac Diethylamine, the active ingredient in Motusol Max 12-Hour Pain Relief, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for cutaneous use. It treats mild to moderate musculoskeletal pain and reduces localized inflammation in adults.

GNH India supplies Motusol Max 12-Hour Pain Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva Uk Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Diclofenac Diethylamine is applied topically to manage pain and inflammation within the musculoskeletal system.

  • Musculoskeletal pain: provides relief of mild to moderate pain in muscles and joints.
  • Sports injuries: reduces pain and swelling associated with strains and sprains.
  • Post‑traumatic sprains: alleviates discomfort and local inflammation.
  • Localized osteoarthritis: helps manage joint pain in affected areas.
  • Localized rheumatoid arthritis flare: reduces inflammation and tenderness at the site of application.

How It Works

  • Diclofenac Diethylamine penetrates the skin and reversibly inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, decreasing the synthesis of prostaglandins that mediate inflammation, pain, and fever. By lowering prostaglandin levels locally, the drug diminishes peripheral sensitisation of nociceptors, resulting in analgesic and anti‑inflammatory effects at the site of application.

Side Effects

Topical diclofenac may cause local skin reactions, though most are mild and reversible.

Common Side Effects

  • Skin irritation: mild redness or discomfort at the application site.
  • Erythema: localized redness of the skin.
  • Pruritus: itching where the gel is applied.
  • Burning sensation: transient warmth or stinging.
  • Dry skin: occasional dryness or flaking.
  • Contact dermatitis: mild allergic skin response.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Stevens‑Johnson syndrome: rare but serious skin disorder.
  • Toxic epidermal necrolysis: life‑threatening skin detachment.
  • Systemic NSAID toxicity: rare systemic effects if absorbed in large amounts.
  • Severe photosensitivity: heightened skin reaction to sunlight.
  • Ulceration: rare skin ulcer formation at the site.

Precautions & Warnings

When using topical diclofenac, consider the following safety measures.

  • Pregnancy: avoid use unless the prescriber determines benefits outweigh risks.
  • Breastfeeding: consult a healthcare professional before application.
  • Concomitant anticoagulants: monitor for increased bleeding tendency.
  • Skin integrity: do not apply to broken, infected, or irritated skin.
  • NSAID allergy: contraindicated in patients with known hypersensitivity to diclofenac or other NSAIDs.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Topical diclofenac can interact with systemic medications; awareness of these interactions helps minimise risk.

Major Interactions (Avoid)

  • Oral anticoagulants: may increase bleeding risk.
  • Systemic NSAIDs: additive toxicity and gastrointestinal risk.
  • Lithium: potential for increased lithium serum levels.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: possible alteration of renal function.
  • Diuretics: heightened risk of renal impairment.
  • Methotrexate: enhanced toxicity when combined with NSAIDs.

Frequently Asked Questions

Motusol Max 12-Hour Pain Relief is a topical NSAID gel containing diclofenac diethylamine. It is used to relieve mild to moderate musculoskeletal pain and to reduce localized inflammation associated with conditions such as sprains, strains, and joint discomfort.

Diclofenac diethylamine works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in the skin. This inhibition reduces the production of prostaglandins, which are mediators of pain and inflammation, thereby providing local analgesic and anti‑inflammatory effects.

The specific dose and frequency are determined by the prescribing healthcare professional based on the severity of pain, the area of application, and individual patient factors. Patients should follow the prescriber’s instructions and the product label.

Safety in pregnancy and lactation has not been definitively established for topical diclofenac. It should be avoided unless the prescriber judges that the potential benefit outweighs any possible risk to the fetus or infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Motusol Max contains diclofenac diethylamine, a well‑studied NSAID with a rapid onset of action. Compared with other topical NSAIDs such as ibuprofen or ketoprofen gels, diclofenac often provides longer‑lasting pain relief and is available in a 12‑hour formulation, which may reduce the frequency of re‑application.

Store the product at room temperature, ideally below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

Apply a thin layer of the gel to the affected skin area and gently rub it in until it disappears. Wash your hands after application, and avoid covering the treated area with airtight dressings unless directed by a healthcare professional.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic NSAID toxicity if significant absorption occurs. Immediate medical attention is required if any of these symptoms develop.

Individuals with a known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation should avoid using the product. It is also contraindicated on broken, infected, or inflamed skin and should be used with caution in patients taking anticoagulants or other systemic NSAIDs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.